Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Rising obesity rates impact fertility among young adults
-
- Diabetes community rallies to meet insulin needs after hurricanes
- FDA approves expanded CV indication for Victoza
- Intraoperative MRI improves complete resection of pituitary macroadenoma Brooke Swearingen, MD; Stephanie L. Lee, MD, PhD, ECNU
- Hormone therapy does not increase mortality risk in postmenopausal women
- Insomnia increases risk for type 2 diabetes
- Kidney disease ‘virtually universal’ at long durations of type 1 diabetes
- Liraglutide reduces adverse renal outcomes
- Abaloparatide, followed by alendronate, reduces risk for all fracture types in postmenopausal women
-
- For patients with diabetes, consider ‘deprescribing’ to improve outcomes
- HbA1c levels, diabetes duration linked to fracture risk
- ‘Osteogenomic profile’ offers personalized fracture risk assessment
- Persistent medication use decreases fracture risk in osteoporosis
- Romosozumab followed by denosumab decreases fracture risk in postmenopausal women
- Simple steps can improve experience, avoid frustrations with CGM
- Which has greater influence on childhood obesity, prenatal or postnatal environment?